Search 

Our breakthrough technology combines synthetic and stem cell biology, offering limitless possibilities. Enabling a new generation of cell therapies, providing the best human cells for research and drug discovery, and allowing the control of advanced synthetic biology circuits for biomanufacturing.

Charnwood Molecular is an integrated drug discovery provider with a 25-year track record of delivery to our clients worldwide, many of whom are emerging pharmaceutical companies.

We believe in bringing together the right experts, technologies, capabilities, and passion, to support customer drug discovery projects and deliver potent, selective, and drug-like candidates.  Our experienced project scientists (medicinal chemistry, biology, computational chemistry, ADME/PK and process chemistry) understand the drug discovery process, the importance of physicochemical properties, the interrogation of biological data and generation of SAR, with expertise in all major disease areas and targets.

Since our inception in 1998 we have successfully supported hundreds of life science groups globally, from academic groups and virtual start-ups to established biotechnology and pharmaceutical companies. We place great emphasis on open collaboration in our client relationships. What makes Charnwood Molecular unique is our unwavering passion for the truly ground-breaking science we facilitate and the trusting relationships we build.

Mironid is an innovative drug discovery company that develops proprietary drug candidate molecules by modulating the activity of key cell signaling proteins.